These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 26293470)

  • 41. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
    N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reassessment of intravenous antibiotic therapy using a reminder or direct counselling.
    Lesprit P; Landelle C; Girou E; Brun-Buisson C
    J Antimicrob Chemother; 2010 Apr; 65(4):789-95. PubMed ID: 20139143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections.
    Wacha H; Warren B; Bassaris H; Nikolaidis P;
    Surg Infect (Larchmt); 2006 Aug; 7(4):341-54. PubMed ID: 16978077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Importance of nondrug costs of intravenous antibiotic therapy.
    van Zanten AR; Engelfriet PM; van Dillen K; van Veen M; Nuijten MJ; Polderman KH
    Crit Care; 2003 Dec; 7(6):R184-90. PubMed ID: 14624694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous-to-oral stepdown program: four years of experience in a large teaching hospital.
    Frighetto L; Nickoloff D; Martinusen SM; Mamdani FS; Jewesson PJ
    Ann Pharmacother; 1992 Nov; 26(11):1447-51. PubMed ID: 1477451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What Stops Doctors Switching from Intravenous to Oral Antibiotics?
    Hogan-Murphy D; Waqas S; Tuite H; Ni Riain U
    Ir Med J; 2019 Sep; 112(8):987. PubMed ID: 31650816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hospital pharmacists' reinforcement of guidelines for switching from parenteral to oral antibiotics: a pilot study.
    von Gunten V; Amos V; Sidler AL; Beney J; Troillet N; Reymond JP
    Pharm World Sci; 2003 Apr; 25(2):52-5. PubMed ID: 12774564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. When are Oral Antibiotics a Safe and Effective Choice for Bacterial Bloodstream Infections? An Evidence-Based Narrative Review.
    Hale AJ; Snyder GM; Ahern JW; Eliopoulos G; Ricotta D; Alston WK
    J Hosp Med; 2018 May; 13(5):328-335. PubMed ID: 29489923
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of computer-based reminders on the management of hospitalized patients with worsening renal function.
    Rind DM; Safran C; Phillips RS; Slack WV; Calkins DR; Delbanco TL; Bleich HL
    Proc Annu Symp Comput Appl Med Care; 1991; ():28-32. PubMed ID: 1807605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of intravenous-to-oral switch guidelines on the use of parenteral antimicrobials in medical wards.
    Laing RB; Mackenzie AR; Shaw H; Gould IM; Douglas JG
    J Antimicrob Chemother; 1998 Jul; 42(1):107-11. PubMed ID: 9700538
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Practice of switch from intravenous to oral antibiotics.
    Shrayteh ZM; Rahal MK; Malaeb DN
    Springerplus; 2014; 3():717. PubMed ID: 25674457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of an intervention aimed at early discontinuation of intravenous antimicrobial therapy in a Brazilian University hospital.
    Bonella GF; Fontes AM; Jorge MT; Silveira AB
    Braz J Infect Dis; 2016; 20(5):462-7. PubMed ID: 27513531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early switch from intravenous to oral antibiotic treatment in bone and joint infections.
    Sendi P; Lora-Tamayo J; Cortes-Penfield NW; Uçkay I
    Clin Microbiol Infect; 2023 Sep; 29(9):1133-1138. PubMed ID: 37182643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical pharmacological considerations in an early intravenous to oral antibiotic switch: are barriers real or simply perceived?
    Landersdorfer CB; Gwee A; Nation RL
    Clin Microbiol Infect; 2023 Sep; 29(9):1120-1125. PubMed ID: 37059222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of an intervention in the use of sequential antibiotic therapy in a Brazilian university hospital.
    Rodrigues RM; Fontes AM; Mantese OC; Martins RS; Jorge MT
    Rev Soc Bras Med Trop; 2013; 46(1):50-4. PubMed ID: 23563825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous to oral antibiotic switch therapy.
    Cunha BA
    Drugs Today (Barc); 2001 May; 37(5):311-319. PubMed ID: 12768219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EBNEO Commentary: Early switching from intravenous to oral antibiotics in neonates with probable bacterial infection.
    Nasef N; Nour I; Abdel-Hady H
    Acta Paediatr; 2023 Apr; 112(4):883-884. PubMed ID: 36578094
    [No Abstract]   [Full Text] [Related]  

  • 58. Oral administration of antibiotics: a rational alternative to the parenteral route.
    MacGregor RR; Graziani AL
    Clin Infect Dis; 1997 Mar; 24(3):457-67. PubMed ID: 9114201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Why do patients with infection remain in hospital once changed to oral antibiotics?
    Boyter AC; Stephen J; Fegan PG; Nathwani D
    J Antimicrob Chemother; 1997 Feb; 39(2):286-8. PubMed ID: 9069557
    [No Abstract]   [Full Text] [Related]  

  • 60. Challenging Dogma in the Treatment of Childhood Infections: Oral Antibiotics and Shorter Durations.
    Tanti DC; Spellberg B; McMullan BJ
    Pediatr Infect Dis J; 2024 Jul; 43(7):e235-e239. PubMed ID: 38564740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.